NCT04871100 Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use
| NCT ID | NCT04871100 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Anxiety Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2026-05-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-03-01 with a primary completion date of 2026-05-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Individual with anxiety and post-traumatic stress disorder often use alcohol in ways that could cause them harm. Treating both mental health concerns and alcohol use at the same time can help reduce difficulties engaging in multiple treatments. The investigators are evaluating how a cognitive behavioral therapy program that helps Veterans with anxiety, posttraumatic stress disorder, and alcohol use at the same time can help improve the participants lives.
Eligibility Criteria
Inclusion Criteria: * meeting diagnostic criteria for current anxiety disorder and * endorsing hazardous alcohol use Exclusion Criteria: -need for acute medically-supervised detoxification with exclusionary criteria of * high-risk suicidality * psychotic symptoms, or * cognitive impairment that could interfere with engagement in weekly psychotherapy
Contact & Investigator
Anthony Ecker, PhD
PRINCIPAL INVESTIGATOR
Michael E. DeBakey VA Medical Center, Houston, TX
Frequently Asked Questions
Who can join the NCT04871100 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04871100 currently recruiting?
Yes, NCT04871100 is actively recruiting participants. Contact the research team at anthony.ecker@va.gov for enrollment information.
Where is the NCT04871100 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT04871100 clinical trial?
NCT04871100 is sponsored by VA Office of Research and Development. The principal investigator is Anthony Ecker, PhD at Michael E. DeBakey VA Medical Center, Houston, TX. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.